{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:46:24Z","timestamp":1778273184895,"version":"3.51.4"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Czech Ministry of Health","award":["IGA NT\/13369"],"award-info":[{"award-number":["IGA NT\/13369"]}]},{"name":"Czech Ministry of Health","award":["NT\/12349"],"award-info":[{"award-number":["NT\/12349"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jsbmb.2014.07.007","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T20:15:15Z","timestamp":1406232915000},"page":"207-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"PB","title":["Endocrine disruptors and other inhibitors of 11\u03b2-hydroxysteroid dehydrogenase 1 and 2: Tissue-specific consequences of enzyme inhibition"],"prefix":"10.1016","volume":"155","author":[{"given":"Jana","family":"Vitku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4589-6050","authenticated-orcid":false,"given":"Luboslav","family":"Starka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Bicikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7466-7532","authenticated-orcid":false,"given":"Jiri","family":"Heracek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Sosvorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hampl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsbmb.2014.07.007_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an endocrine society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr. Rev."},{"issue":"6854","key":"10.1016\/j.jsbmb.2014.07.007_bib0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bmj.305.6854.609","article-title":"Evidence for decreasing quality of semen during past 50 years","volume":"305","author":"Carlsen","year":"1992","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2605.2007.00853.x","article-title":"Adverse trends in male reproductive health: we may have reached a crucial \u2018tipping point\u2019","volume":"31","author":"Andersson","year":"2008","journal-title":"Int. J. Androl."},{"issue":"5727","key":"10.1016\/j.jsbmb.2014.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.1108190","article-title":"Epigenetic transgenerational actions of endocrine disruptors and male fertility","volume":"308","author":"Anway","year":"2005","journal-title":"Science."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0025","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1289\/ehp.11338","article-title":"Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit","volume":"116","author":"Rusiecki","year":"2008","journal-title":"Environ. Health Perspect."},{"issue":"32","key":"10.1016\/j.jsbmb.2014.07.007_bib0030","doi-asserted-by":"crossref","first-page":"13056","DOI":"10.1073\/pnas.0703739104","article-title":"Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development","volume":"104","author":"Dolinoy","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.jsbmb.2014.07.007_bib0035","doi-asserted-by":"crossref","first-page":"p. e40056","DOI":"10.1371\/journal.pone.0040056","article-title":"BVT. 2733, a selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.jsbmb.2014.07.007_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2012.06.024","article-title":"Anti-diabetic and anti-adipogenic effects of a novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice","volume":"691","author":"Park","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.07.007_bib0045","first-page":"266","article-title":"INCB-13739, an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for the treatment of type 2 diabetes","volume":"13","author":"Tiwari","year":"2010","journal-title":"IDrugs"},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0050","doi-asserted-by":"crossref","first-page":"p. e295","DOI":"10.1038\/tp.2013.67","article-title":"Peripheral and central nervous system inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384","volume":"3","author":"Katz","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.jsbmb.2014.07.007_bib0055","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jcem-13-9-1125","article-title":"Conversion of cortisone to compound F","volume":"13","author":"Amelung","year":"1953","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8618","key":"10.1016\/j.jsbmb.2014.07.007_bib0060","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11beta-hydroxysteroid dehydrogenase \u2013 tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"issue":"4878","key":"10.1016\/j.jsbmb.2014.07.007_bib0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science."},{"issue":"1\u20133","key":"10.1016\/j.jsbmb.2014.07.007_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.febslet.2004.06.065","article-title":"Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase","volume":"571","author":"Atanasov","year":"2004","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.jsbmb.2014.07.007_bib0075","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.bbamcr.2008.03.001","article-title":"Direct protein\u2013protein interaction of 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen","volume":"1783","author":"Atanasov","year":"2008","journal-title":"Biochim. Biophys. Acta."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1677\/jme.1.01718","article-title":"Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11beta-hydroxysteroid dehydrogenase type 1","volume":"34","author":"Bujalska","year":"2005","journal-title":"J. Mol. Endocrinol."},{"issue":"26","key":"10.1016\/j.jsbmb.2014.07.007_bib0085","doi-asserted-by":"crossref","first-page":"27017","DOI":"10.1074\/jbc.M404159200","article-title":"Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum","volume":"279","author":"Banhegyi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"42","key":"10.1016\/j.jsbmb.2014.07.007_bib0090","doi-asserted-by":"crossref","first-page":"25959","DOI":"10.1016\/S0021-9258(18)47142-6","article-title":"NAD(+)-dependent isoform of 11beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney","volume":"269","author":"Agarwal","year":"1994","journal-title":"J Biol Chem."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.07.007_bib0095","first-page":"1334","article-title":"Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase","volume":"79","author":"Kenouch","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.07.007_bib0100","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1210\/en.2005-0046","article-title":"11{Beta}-hydroxysteroid dehydrogenase 2 in rat Leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate","volume":"146","author":"Ge","year":"2005","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.jsbmb.2014.07.007_bib0105","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1210\/endo.132.6.8504762","article-title":"Human placental 11beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform","volume":"132","author":"Brown","year":"1993","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jsbmb.2014.07.007_bib0110","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo-128-4-1741","article-title":"Regional distribution of 11beta-hydroxysteroid dehydrogenase in rat brain","volume":"128","author":"Lakshmi","year":"1991","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.jsbmb.2014.07.007_bib0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-2007-979079","article-title":"Inhibition of rat renal and testicular 11beta-hydroxysteroid dehydrogenase by some antihypertensive drugs, diuretics, and epitestosterone","volume":"29","author":"Bicikova","year":"1997","journal-title":"Horm. Metab. Res."},{"issue":"25","key":"10.1016\/j.jsbmb.2014.07.007_bib0120","doi-asserted-by":"crossref","first-page":"16,653","DOI":"10.1016\/S0021-9258(18)55351-5","article-title":"The human gene for 11beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization","volume":"266","author":"Tannin","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.07.007_bib0125","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1210\/endo-129-6-3305","article-title":"11Beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids","volume":"129","author":"Walker","year":"1991","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1677\/joe.0.1350053","article-title":"11Beta-hydroxysteroid dehydrogenase in the rat ovary: high expression in the oocyte","volume":"135","author":"Benediktsson","year":"1992","journal-title":"J. Endocrinol."},{"issue":"7","key":"10.1016\/j.jsbmb.2014.07.007_bib0135","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/qjmed\/hcg085","article-title":"Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension","volume":"96","author":"Rauz","year":"2003","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ki.1996.39","article-title":"Immunolocalization of NAD-dependent 11beta-hydroxysteroid dehydrogenase in human kidney and colon","volume":"49","author":"Kyossev","year":"1996","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0145","first-page":"3859","article-title":"Colocalization of 11beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia","volume":"82","author":"Hirasawa","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0150","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","article-title":"Cloning and tissue distribution of the human 11beta-hydroxysteroid dehydrogenase type 2 enzyme","volume":"105","author":"Albiston","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6\u20137","key":"10.1016\/j.jsbmb.2014.07.007_bib0155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1681.1996.tb02776.x","article-title":"Vascular localization of the 11beta-hydroxysteroid dehydrogenase type II enzyme","volume":"23","author":"Smith","year":"1996","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.07.007_bib0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0039-128X(97)00011-1","article-title":"The sheep kidney contains a novel unidirectional, high affinity NADP(+)-dependent 11beta-hydroxysteroid dehydrogenase (11beta-HSD-3)","volume":"62","author":"Gomez-Sanchez","year":"1997","journal-title":"Steroids"},{"issue":"1\u20133","key":"10.1016\/j.jsbmb.2014.07.007_bib0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.febslet.2004.08.023","article-title":"Evolutionary analysis of 11beta-hydroxysteroid dehydrogenase-type 1, -type 2 -type 3 and 17beta-hydroxysteroid dehydrogenase-type 2 in fish","volume":"574","author":"Baker","year":"2004","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0170","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.febslet.2010.03.036","article-title":"Evolution of 11beta-hydroxysteroid dehydrogenase-type 1 and 11beta-hydroxysteroid dehydrogenase-type 3","volume":"584","author":"Baker","year":"2010","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.18388\/abp.2009_2460","article-title":"Isolation and characterization of novel human short-chain dehydrogenase\/reductase SCDR10B which is highly expressed in the brain and acts as hydroxysteroid dehydrogenase","volume":"56","author":"Huang","year":"2009","journal-title":"Acta Biochim. Pol."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.07.007_bib0180","first-page":"219","article-title":"Inhibitory effects of some possible endocrine-disrupting chemicals on the isozymes of human 11beta-hydroxysteroid dehydrogenase and expression of their mRNA in gonads and adrenal glands","volume":"12","author":"Ohshima","year":"2005","journal-title":"Environ. Sci."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.07.007_bib0185","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1046\/j.1523-1755.2000.00967.x","article-title":"Expression of the 11beta-hydroxysteroid dehydrogenase 2 gene in the mouse","volume":"57","author":"Moore","year":"2000","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.steroids.2007.11.006","article-title":"Chicken 11beta-hydroxysteroid dehydrogenase type 2: partial cloning and tissue distribution","volume":"73","author":"Klusonova","year":"2008","journal-title":"Steroids"},{"issue":"3\u20135","key":"10.1016\/j.jsbmb.2014.07.007_bib0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jsbmb.2008.06.004","article-title":"Cloning of chicken 11beta-hydroxysteroid dehydrogenase type 1 and its tissue distribution","volume":"111","author":"Klusonova","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/joe.0.1590233","article-title":"11Beta-hydroxysteroid dehydrogenase is a predominant reductase in intact rat Leydig cells","volume":"159","author":"Leckie","year":"1998","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0205","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/endo.138.1.4837","article-title":"Hormonal regulation of oxidative and reductive activities of 11beta-hydroxysteroid dehydrogenase in rat Leydig cells","volume":"138","author":"Gao","year":"1997","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/j.1939-4640.2000.tb02108.x","article-title":"Initial predominance of the oxidative activity of type I 11beta-hydroxysteroid dehydrogenase in primary rat Leydig cells and transfected cell lines","volume":"21","author":"Ge","year":"2000","journal-title":"J. Androl."},{"issue":"12","key":"10.1016\/j.jsbmb.2014.07.007_bib0215","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1210\/endo.138.12.5614","article-title":"Developmental changes in glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase oxidative and reductive activities in rat Leydig cells","volume":"138","author":"Ge","year":"1997","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/REP-07-0126","article-title":"11Beta-hydroxysteroid dehydrogenase enzymes in the testis and male reproductive tract of the boar (Sus scrofa domestica) indicate local roles for glucocorticoids in male reproductive physiology","volume":"134","author":"Sharp","year":"2007","journal-title":"Reproduction"},{"issue":"3\u20135","key":"10.1016\/j.jsbmb.2014.07.007_bib0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jsbmb.2009.03.009","article-title":"Expression and activities of 11betaHSD enzymes in the testes and reproductive tracts of sexually immature male pigs","volume":"115","author":"Sharp","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"9\u201310","key":"10.1016\/j.jsbmb.2014.07.007_bib0230","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.steroids.2007.12.020","article-title":"Rapid mechanisms of glucocorticoid signaling in the Leydig cell","volume":"73","author":"Hu","year":"2008","journal-title":"Steroids"},{"issue":"7","key":"10.1016\/j.jsbmb.2014.07.007_bib0235","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.steroids.2011.03.007","article-title":"Role of 11beta-OH\u2013C(19) and C(21) steroids in the coupling of 11beta-HSD1 and 17beta-HSD3 in regulation of testosterone biosynthesis in rat Leydig cells","volume":"76","author":"Latif","year":"2011","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0240","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1210\/en.2012-1778","article-title":"The microsomal enzyme 17beta-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase","volume":"154","author":"Legeza","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0245","series-title":"Endocrine-Disrupting Chemicals: From Basic Research to Clinical Practice","article-title":"Epidemiologic evidence on the relationship between environmental endocrine disruptors and male reproductive and developmental health","author":"Hauser","year":"2010"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4149\/endo_2013_03_149","article-title":"Hormones and endocrine disruptors in human seminal plasma","volume":"47","author":"Hampl","year":"2013","journal-title":"Endocr. Reg."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/JOE-13-0066","article-title":"Resveratrol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes","volume":"218","author":"Tagawa","year":"2013","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0260","doi-asserted-by":"crossref","first-page":"p. e49976","DOI":"10.1371\/journal.pone.0049976","article-title":"Curcumin as a potent and selective inhibitor of 11beta-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats","volume":"8","author":"Hu","year":"2013","journal-title":"PLos One"},{"issue":"9","key":"10.1016\/j.jsbmb.2014.07.007_bib0265","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/aps.2012.87","article-title":"Emodin, an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob\/ob mice","volume":"33","author":"Wang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1476-5381.2010.00826.x","article-title":"Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice","volume":"161","author":"Feng","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2014.07.007_bib0275","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mce.2003.09.027","article-title":"A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity","volume":"212","author":"Schweizer","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0280","first-page":"826","article-title":"Inhibition of 11b-HSD1 by tetracyclic triterpenoids from Euphorbia kansui","volume":"11","author":"Guo","year":"2012","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0285","doi-asserted-by":"crossref","first-page":"p. e84468","DOI":"10.1371\/journal.pone.0084468","article-title":"Green tea and one of its constituents, epigallocatechine-3-gallate, are potent inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1","volume":"9","author":"Hintzpeter","year":"2014","journal-title":"PLos One"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0290","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.toxlet.2012.10.002","article-title":"Inhibition of human and rat 11beta-hydroxysteroid dehydrogenases activities by bisphenol A","volume":"215","author":"Guo","year":"2012","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxlet.2013.01.002","article-title":"Effects of methoxychlor and its metabolite 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane on 11beta-hydroxysteroid dehydrogenase activities in vitro","volume":"218","author":"Guo","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"Pt 3","key":"10.1016\/j.jsbmb.2014.07.007_bib0300","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1042\/bj3131007","article-title":"Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2","volume":"313","author":"Brown","year":"1996","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0305","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1289\/ehp.8209","article-title":"Organotins disrupt the 11beta-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids","volume":"113","author":"Atanasov","year":"2005","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0310","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-291X(03)01359-7","article-title":"Inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by dithiocarbamates","volume":"308","author":"Atanasov","year":"2003","journal-title":"Biochem. Biophy. Res. Commun."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cbi.2009.09.014","article-title":"Structure-dependent inhibition of human and rat 11beta-hydroxysteroid dehydrogenase 2 activities by phthalates","volume":"183","author":"Zhao","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2014.07.007_bib0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jsbmb.2010.12.017","article-title":"The inhibition of human and rat 11beta-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substances","volume":"125","author":"Zhao","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.07.007_bib0325","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI37398","article-title":"Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans","volume":"119","author":"Zhang","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.07.007_bib0330","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1172\/JCI38936","article-title":"Can licorice lick colon cancer?","volume":"119","author":"Stewart","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0335","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.jsbmb.2014.07.007_bib0340","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0345","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/jpet.113.207118","article-title":"NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?","volume":"348","author":"Fornai","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0350","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gtc.2010.08.010","article-title":"Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention","volume":"39","author":"Scarpignato","year":"2010","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2014.07.007_bib0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsbmb.2010.12.019","article-title":"Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11beta-hydroxysteroid dehydrogenase type 2","volume":"125","author":"Kratschmar","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2003.12.019","article-title":"Expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer","volume":"210","author":"Zbankova","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0365","article-title":"Expression of 11beta-hydroxysteroid dehydrogenase type 2 is deregulated in colon carcinoma","author":"Moravec","year":"2013","journal-title":"Histol. Histopathol."},{"issue":"9060","key":"10.1016\/j.jsbmb.2014.07.007_bib0370","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(96)11222-8","article-title":"Does central obesity reflect Cushing\u2019s disease of the omentum?","volume":"349","author":"Bujalska","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0375","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.2006.02552.x","article-title":"Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women","volume":"65","author":"Goedecke","year":"2006","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"10.1016\/j.jsbmb.2014.07.007_bib0380","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/sj.ijo.0803677","article-title":"Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects","volume":"31","author":"Alberti","year":"2007","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0385","first-page":"1205","article-title":"A switch in dehydrogenase to reductase activity of 11beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells","volume":"87","author":"Bujalska","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jsbmb.2014.07.007_bib0390","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/oby.2007.233","article-title":"11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization","volume":"15","author":"Paulsen","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0395","doi-asserted-by":"crossref","first-page":"787201","DOI":"10.5402\/2012\/787201","article-title":"Differences in expression, content, and activity of 11beta-HSD1 in adipose tissue between obese men and women","volume":"2012","author":"Torres","year":"2012","journal-title":"ISRN Endocrinol."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.07.007_bib0400","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1210\/jc.2002-030017","article-title":"Subcutaneous adipose 11beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians","volume":"88","author":"Lindsay","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.jsbmb.2014.07.007_bib0405","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1210\/jc.2004-0153","article-title":"Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins","volume":"89","author":"Kannisto","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0410","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","article-title":"Tissue-specific dysregulation of cortisol metabolism in human obesity","volume":"86","author":"Rask","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.07.007_bib0415","doi-asserted-by":"crossref","first-page":"E543","DOI":"10.1152\/ajpendo.00491.2013","article-title":"Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice","volume":"306","author":"Wang","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.07.007_bib0420","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1210\/en.2005-0117","article-title":"Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity","volume":"146","author":"Hewitt","year":"2005","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0425","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1677\/JOE-08-0050","article-title":"A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis","volume":"197","author":"Bujalska","year":"2008","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.07.007_bib0430","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI114345","article-title":"Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium","volume":"84","author":"Hauner","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0435","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0014-4827(91)90261-R","article-title":"Glucocorticoids induce a drastic inhibition of proliferation and stimulate differentiation of adult rat fat cell precursors","volume":"196","author":"Gregoire","year":"1991","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0440","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000115363","article-title":"11Beta-hydroxysteroid dehydrogenase type 1 and obesity","volume":"36","author":"Morton","year":"2008","journal-title":"Front. Horm. Res."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0445","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1021\/jm4014746","article-title":"Medicinal chemistry of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)","volume":"57","author":"Scott","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.metabol.2012.05.002","article-title":"11Beta-hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?","volume":"62","author":"Anagnostis","year":"2013","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.jsbmb.2014.07.007_bib0455","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1463-1326.2012.01582.x","article-title":"11Beta-hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus","volume":"14","author":"Pereira","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2014.07.007_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2010.01.007","article-title":"The glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 has broad substrate specificity: physiological and toxicological considerations","volume":"119","author":"Odermatt","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0465","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1038\/srep03879","article-title":"Treatment of obesity with the resveratrol-enriched rice DJ-526","volume":"4","author":"Baek","year":"2014","journal-title":"Sci. Rep."},{"issue":"7117","key":"10.1016\/j.jsbmb.2014.07.007_bib0470","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0475","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11695-010-0251-7","article-title":"Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARgamma1-3 mRNA expression in human visceral adipocytes","volume":"21","author":"Costa Cdos","year":"2011","journal-title":"Obes. Surg."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.07.007_bib0480","first-page":"850","article-title":"[Effects of resveratrol on pig primary preadipocytes proliferation, differentiation and transcription expression of Sirt1 gene]","volume":"22","author":"Pang","year":"2006","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0485","article-title":"Resveratrol appears to protect against oxidative stress and steroidogenesis collapse in mice fed high-calorie and high-cholesterol diet","author":"Wang","year":"2014","journal-title":"Andrologia"},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0490","first-page":"3155","article-title":"Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation","volume":"80","author":"Walker","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0495","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2002-021194","article-title":"Effects of the 11beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes","volume":"88","author":"Andrews","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0500","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11Beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0505","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bmcl.2013.11.066","article-title":"Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)","volume":"24","author":"Ye","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.jsbmb.2014.07.007_bib0510","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ijo.2012.173","article-title":"The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11beta-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children","volume":"37","author":"Wang","year":"2013","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"10","key":"10.1016\/j.jsbmb.2014.07.007_bib0515","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0520","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-800095-3.00009-2","article-title":"Nuclear receptor profiling of bisphenol-A and its halogenated analogues","volume":"94","author":"Delfosse","year":"2014","journal-title":"Vitam. Horm."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0525","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1289\/ehp.10587","article-title":"Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma","volume":"116","author":"Okada","year":"2008","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0530","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/toxsci\/kfg150","article-title":"Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor","volume":"75","author":"Lee","year":"2003","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0535","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cbi.2013.03.013","article-title":"Bisphenol A affects androgen receptor function via multiple mechanisms","volume":"203","author":"Teng","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0540","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1210\/jc.2002-020209","article-title":"Thyroid hormone action is disrupted by bisphenol A as an antagonist","volume":"87","author":"Moriyama","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jsbmb.2014.07.007_bib0545","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/oby.2009.419","article-title":"Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation","volume":"18","author":"Sargis","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"10.1016\/j.jsbmb.2014.07.007_bib0550","doi-asserted-by":"crossref","first-page":"e77481","DOI":"10.1371\/journal.pone.0077481","article-title":"Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect","volume":"8","author":"Pereira-Fernandes","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jsbmb.2014.07.007_bib0555","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s10529-010-0359-9","article-title":"A recombinant peroxisome proliferator response element-driven luciferase assay for evaluation of potential environmental obesogens","volume":"32","author":"Wang","year":"2010","journal-title":"Biotechnol. Lett."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0560","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1289\/ehp.1104426","article-title":"Bisphenol A and its analogues activate human pregnane X receptor","volume":"120","author":"Sui","year":"2012","journal-title":"Environ. Health Perspect."},{"issue":"8","key":"10.1016\/j.jsbmb.2014.07.007_bib0565","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1289\/ehp.8002","article-title":"Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans","volume":"113","author":"Alonso-Magdalena","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0570","article-title":"Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist","volume":"02","author":"Boucher","year":"2014","journal-title":"Nutr. Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2014.07.007_bib0575","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jsbmb.2011.01.005","article-title":"Minireview: PPARgamma as the target of obesogens","volume":"127","author":"Janesick","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0580","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2605.2012.01247.x","article-title":"Obesogens, stem cells and the developmental programming of obesity","volume":"35","author":"Janesick","year":"2012","journal-title":"Int. J. Androl."},{"issue":"5\u20136","key":"10.1016\/j.jsbmb.2014.07.007_bib0585","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0960-0760(95)00194-8","article-title":"The human 11beta-hydroxysteroid dehydrogenase type II enzyme: comparisons with other species and localization to the distal nephron","volume":"55","author":"Krozowski","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0590","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0889-8529(18)30102-6","article-title":"Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess","volume":"23","author":"Walker","year":"1994","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2014.07.007_bib0595","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0303-7207(02)00041-2","article-title":"Steroidogenic enzyme gene expression in the human brain","volume":"190","author":"Yu","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0600","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.yfrne.2010.12.001","article-title":"11Beta-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress","volume":"32","author":"Wyrwoll","year":"2011","journal-title":"Front. Neuroendocrino."},{"issue":"17","key":"10.1016\/j.jsbmb.2014.07.007_bib0605","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1073\/pnas.0306996101","article-title":"11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics","volume":"101","author":"Sandeep","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.07.007_bib0610","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/jne.12017","article-title":"Expression of 11beta-hydroxysteroid dehydrogenase type 1 in the human hypothalamus","volume":"25","author":"Bisschop","year":"2013","journal-title":"J. Neuroendocrinol."},{"issue":"9","key":"10.1016\/j.jsbmb.2014.07.007_bib0615","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tem.2004.09.007","article-title":"11Beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory","volume":"15","author":"Seckl","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0620","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1523\/JNEUROSCI.2783-10.2010","article-title":"Partial deficiency or short-term inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice","volume":"30","author":"Sooy","year":"2010","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0625","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2826.2009.01899.x","article-title":"Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent","volume":"21","author":"Carter","year":"2009","journal-title":"J. Neuroendocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0630","first-page":"300","article-title":"Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes","volume":"82","author":"Sun","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2014.07.007_bib0635","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/07435809509030454","article-title":"Clinical investigation of 11beta-hydroxysteroid dehydrogenase","volume":"21","author":"Walker","year":"1995","journal-title":"Endocr. Res."},{"issue":"7","key":"10.1016\/j.jsbmb.2014.07.007_bib0640","first-page":"2203","article-title":"Immunohistochemical localization of the 11beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta","volume":"80","author":"Krozowski","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.jsbmb.2014.07.007_bib0645","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0026-0495(99)90249-4","article-title":"Influence of placental 11beta-hydroxysteroid dehydrogenase (11beta-HSD) inhibition on glucose metabolism and 11beta-HSD regulation in adult offspring of rats","volume":"48","author":"Saegusa","year":"1999","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.jsbmb.2014.07.007_bib0650","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9378(16)33697-3","article-title":"Conversion of maternal cortisol to cortisone during placental transfer to the human fetus","volume":"118","author":"Murphy","year":"1974","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0655","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jsbmb.2013.03.008","article-title":"Steroid profiling in pregnancy: a focus on the human fetus","volume":"139","author":"Hill","year":"2014","journal-title":"J. Steroid Biochem. Mol. Bio."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.07.007_bib0660","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/01.HYP.27.6.1200","article-title":"Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring","volume":"27","author":"Lindsay","year":"1996","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.jsbmb.2014.07.007_bib0665","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s001250050573","article-title":"Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone","volume":"39","author":"Lindsay","year":"1996","journal-title":"Diabetologia"},{"issue":"6673","key":"10.1016\/j.jsbmb.2014.07.007_bib0670","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","article-title":"Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease","volume":"298","author":"Barker","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.jsbmb.2014.07.007_bib0675","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.socscimed.2014.02.015","article-title":"Birth weight and adult health in historical perspective: evidence from a New Zealand cohort, 1907\u20131922","volume":"107","author":"Roberts","year":"2014","journal-title":"Soc. Sci. Med."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.07.007_bib0680","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ede.0000172134.45742.49","article-title":"Birth characteristics and risk of high systolic blood pressure in early adulthood: socioeconomic factors and familial effects","volume":"16","author":"Bergvall","year":"2005","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.07.007_bib0685","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/HJH.0b013e328340aa18","article-title":"Prenatal overexposure to glucocorticoids programs renal 11beta-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat","volume":"29","author":"Tang","year":"2011","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0690","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1460-9568.2000.00958.x","article-title":"Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring","volume":"12","author":"Welberg","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0695","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11beta-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-\/- mice","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.07.007_bib0700","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yhbeh.2010.06.007","article-title":"Glucocorticoids, prenatal stress and the programming of disease","volume":"59","author":"Harris","year":"2011","journal-title":"Horm. Behav."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.07.007_bib0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2013.09.001","article-title":"Novel insights of dietary polyphenols and obesity","volume":"25","author":"Wang","year":"2014","journal-title":"J. Nutr. Biochem."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076014001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076014001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:49:17Z","timestamp":1760744957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076014001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":141,"alternative-id":["S0960076014001319"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.07.007","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine disruptors and other inhibitors of 11\u03b2-hydroxysteroid dehydrogenase 1 and 2: Tissue-specific consequences of enzyme inhibition","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}